A recent study discovered a new link between taking GLP-1 drugs and elevated risk of pancreatitis and kidney conditions, including kidney stones.
Concurrently, advanced molecular therapeutics are emerging, including mitophagy inducers (e.g., urolithin A, nicotinamide riboside) to restore mitochondrial quality control (187, 188), gut microbiome engineering to reduce systemic inflammation (189), and innovative RNA therapeutics and gene circuits (e.g., olezarsen, the CHARM system) for long-term management of dyslipidemia (182, 183)
16 The effect was large enough to matter clinically, not just statistically
Understanding why this happens and how to manage it can help you stay committed to your weight loss goals while your body adapts to the medication
: XXIX
However, they are still sensitive to moisture and light